Harry Rowland

Harry D. Rowland is a MedTech Entrepreneur, Board Member, and Advisor. He was recently co-founder, CEO, and President of Endotronix. He led a team that created the Cordella Heart Failure System and Cordella Pulmonary Artery Sensor System, raised $150M+ financing, built a 150+ person organization, completed the PROACTIVE-HF trial, and achieved FDA PMA approval, resulting in acquisition by Edwards Lifesciences in 2024. He joined Edwards for the following year, supporting Cordella's receipt of CMS national coverage and CE Mark, transition and integration activities, and commercial launch. He received his PhD in mechanical engineering from the Georgia Institute of Technology, a BS in mechanical engineering, and a MA in economics from the University of California, Santa Barbara. He has authored numerous scientific journal publications and issued patents.